Reporting owner · CIK 0002005463

Muken Ross

SEC Form 4 history for the last 180 days across 1 company, 3 transactions and 3 filings.

CEOChief Executive OfficerSOPHiA GENETICS SA
Open-market transaction mix33% buys1 buy · 2 sales

Period: Last 180 days

Trade dates in this period: Sep 21, 2026 – Nov 6, 2026

Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.

Filings3Form 4 records
Buying$137k1 purchase
Selling$83.5k2 sales
Net value+$53.7kBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from the last 180 days.
Muken Ross transactions · 20 per page
CompanyActivityDisclosed valueFiled (ET)
SOPHSOPHiA GENETICS SA
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
SEC filing ↗
$137kView disclosure →
SOPHSOPHiA GENETICS SA
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$80.0kView disclosure →
SOPHSOPHiA GENETICS SA
CEO
CEO. Role codes can represent multiple titles; the list does not include the filing title.
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$3.52kView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

The insider reported a buy at SOPHiA GENETICS SA on Nov 6, 2026 valued at $137,188.

Review SEC filing
Latest sale

The insider reported a sale at SOPHiA GENETICS SA on Oct 5, 2026 valued at $79,971.13.

Review SEC filing

Monthly open-market activity

Last 3 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Sep 202601$0$3,515.26−$3,515.26
Oct 202601$0$79,971.13−$79,971.13
Nov 202610$137,188$0+$137,188

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$73.6k
Median P/S size$80.0k
Direct3
Indirect0
Nov 6, 2026buy

Associated companies

Counts cover all available history, including outside the summary period

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

No purchases currently have the price observations needed for a 90-day return. This may reflect incomplete price coverage or purchases that have not reached the return window.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

3 observations · Sep 21, 2026 – Nov 6, 2026. Window ends at the latest available report, not today.

Selected observation · Nov 6, 2026680,391 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Sep 21, 2026670,229Sep 22, 2026View transaction
Oct 5, 2026660,391Oct 7, 2026View transaction
Nov 6, 2026680,391Nov 9, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Muken Ross Insider Activity FAQ

SEC Form 4 context

Who is Muken Ross?

Muken Ross is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002005463.

Which companies has Muken Ross reported transactions for?

SOPHiA GENETICS SA

When was Muken Ross's latest insider buy?

The insider reported a buy at SOPHiA GENETICS SA on Nov 6, 2026 valued at $137,188.

When was Muken Ross's latest insider sale?

The insider reported a sale at SOPHiA GENETICS SA on Oct 5, 2026 valued at $79,971.13.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.